Does receiving a leaflet about the symptoms of gynaecological cancers affect women's attendance at their GP practice?

Evaluating the impact of a leaflet to raise awareness in women of symptoms of gynaecological cancers in primary care: a record-based randomised control trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN61738692

Enrollment

16054

Registered

2017-08-23

Start date

2014-06-03

Completion date

Unknown

Last updated

2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynaecological cancers Cancer

Interventions

Intervention: Educational leaflet on the symptoms of gynaecological cancer sent by post from their GP practice. Control: No leaflet sent. Eligible women were identified from GP electronic records and

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women registered with one of the study GP practices 2. Aged 40 years or over

Exclusion criteria

Exclusion criteria: 1. Women on the oncology and palliative care registers 2. Learning difficulties 3. Mental health problems

Design outcomes

Primary

Measure	Time frame
The proportion of eligible women who consult their GP for symptoms indicative of gynaecological cancers. This was measured by the presence, and dates, of one or more Read codes in the women's electronic patient record that related to the symptoms described in the educational leaflet and which were indicative of gynaecological cancers. The data was extracted for the 4-month time period starting on the day after the GP practice mail out date (for both experimental and control groups)	—

Measure

Time frame

The proportion of eligible women who consult their GP for symptoms indicative of gynaecological cancers. This was measured by the presence, and dates, of one or more Read codes in the women's electronic patient record that related to the symptoms described in the educational leaflet and which were indicative of gynaecological cancers. The data was extracted for the 4-month time period starting on the day after the GP practice mail out date (for both experimental and control groups)

—

Secondary

Measure	Time frame
The proportions of eligible women whose GP practice electronic record contained evidence of referrals, diagnostic tests and diagnoses assosiated with gynaecological cancers. These was measured by the presence, and dates, of one or more Read codes in the women's electronic patient record that related to referrals, diagnostic tests and diagnoses associated with gynaecological cancers. The data was extracted for the 4-month time period starting on the day after the GP practice mail out date (for both experimental and control groups)	—

Measure

Time frame

The proportions of eligible women whose GP practice electronic record contained evidence of referrals, diagnostic tests and diagnoses assosiated with gynaecological cancers. These was measured by the presence, and dates, of one or more Read codes in the women's electronic patient record that related to referrals, diagnostic tests and diagnoses associated with gynaecological cancers. The data was extracted for the 4-month time period starting on the day after the GP practice mail out date (for both experimental and control groups)

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026